Standout Papers
Immediate Impact
1 by Nobel laureates 11 from Science/Nature 66 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
2022 Standout
Works of Avishay Sella being referenced
Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial
2019
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Avishay Sella | 1733 | 1195 | 1743 | 105 | 3.6k | |
| Richard Cathomas | 1244 | 1394 | 1873 | 145 | 3.8k | |
| Alan Yagoda | 1893 | 2313 | 3353 | 103 | 6.0k | |
| Charles C. Guo | 1657 | 852 | 2591 | 130 | 4.7k | |
| Pablo Maroto | 1746 | 1505 | 1605 | 162 | 3.8k | |
| Maria Rosaria Raspollini | 1146 | 1096 | 1144 | 144 | 3.8k | |
| Shaobo Zhang | 1529 | 494 | 1586 | 98 | 3.5k | |
| Theresa M. Koppie | 1281 | 894 | 2322 | 71 | 4.1k | |
| Danai Daliani | 1235 | 1084 | 780 | 51 | 2.8k | |
| Antoine Valéri | 1734 | 519 | 938 | 116 | 2.9k | |
| C.C. Abbou | 2476 | 665 | 2195 | 138 | 4.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...